share_log

HC Wainwright & Co.:维持Revance Therapeutics(RVNC.US)评级,由买入调整至买入评级, 目标价由12.00美元调整至11.00美元。

Zhitong Finance ·  May 13 12:45

HC Wainwright & Co.:维持Revance Therapeutics(RVNC.US)评级,由买入调整至买入评级, 目标价由12.00美元调整至11.00美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment